Adaptive Biotechnologies Corp. (ADPT)
29.04
-0.44
(-1.49%)
USD |
NASDAQ |
Nov 13, 16:00
29.04
0.00 (0.00%)
After-Hours: 19:59
Adaptive Biotechnologies Price to Book Value : 26.63 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 27.03 |
| November 11, 2026 | 27.45 |
| November 10, 2026 | 26.92 |
| November 09, 2026 | 27.74 |
| November 06, 2026 | 25.65 |
| November 05, 2026 | 24.60 |
| November 04, 2026 | 24.49 |
| November 03, 2026 | 23.66 |
| November 02, 2026 | 22.98 |
| October 30, 2026 | 24.43 |
| October 29, 2026 | 25.83 |
| October 28, 2026 | 26.01 |
| October 27, 2026 | 25.36 |
| October 26, 2026 | 24.09 |
| October 23, 2026 | 23.39 |
| October 22, 2026 | 22.38 |
| October 21, 2026 | 23.22 |
| October 20, 2026 | 22.39 |
| October 19, 2026 | 21.96 |
| October 16, 2026 | 22.02 |
| October 15, 2026 | 23.45 |
| October 14, 2026 | 23.49 |
| October 13, 2026 | 23.18 |
| October 12, 2026 | 23.44 |
| October 09, 2026 | 24.29 |
| Date | Value |
|---|---|
| October 08, 2026 | 23.92 |
| October 07, 2026 | 24.10 |
| October 06, 2026 | 24.66 |
| October 05, 2026 | 27.36 |
| October 02, 2026 | 25.99 |
| October 01, 2026 | 25.10 |
| September 30, 2026 | 26.50 |
| September 29, 2026 | 32.02 |
| September 28, 2026 | 31.73 |
| September 25, 2026 | 32.75 |
| September 24, 2026 | 32.91 |
| September 23, 2026 | 31.04 |
| September 22, 2026 | 31.23 |
| September 21, 2026 | 31.01 |
| September 18, 2026 | 31.84 |
| September 17, 2026 | 31.78 |
| September 16, 2026 | 30.80 |
| September 15, 2026 | 29.69 |
| September 14, 2026 | 27.58 |
| September 11, 2026 | 26.93 |
| September 10, 2026 | 26.97 |
| September 09, 2026 | 27.18 |
| September 08, 2026 | 27.09 |
| September 04, 2026 | 27.02 |
| September 03, 2026 | 27.35 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Champions Oncology, Inc. | 16.73 |
| Medpace Holdings, Inc. | 31.17 |
| Avantor, Inc. | 1.803 |
| Personalis, Inc. | 8.003 |
| 10X Genomics, Inc. | 9.128 |
Price to Book Value Related Metrics
| PS Ratio | 15.97 |
| Price | 29.04 |
| Earnings Yield | -1.55% |
| Market Cap | 4.692B |